Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is ¥157,164.85, with a 24-hour trading volume of ¥605.78B. The asset's market cap is ¥140.66T, after moving -1.85% in the last day.
Tokenized Eli Lilly And Co is trading at ¥157,192.28, with a tokenized market cap of ¥840.22M and a 24-hour trading volume of ¥430.73M. The tokenized asset has moved -1.28% in the past 24 hours.